Edition:
India

Wolters Kluwer NV (WLSNc.AS)

WLSNc.AS on Amsterdam Stock Exchange

72.88EUR
18 Sep 2020
Change (% chg)

€-0.04 (-0.05%)
Prev Close
€72.92
Open
€72.92
Day's High
€73.24
Day's Low
€72.82
Volume
803,644
Avg. Vol
591,057
52-wk High
€73.40
52-wk Low
€52.04

Latest Key Developments (Source: Significant Developments)

Wolters Kluwer Legal & Regulatory U.S. Announces Partnership With Oxford University Press
Thursday, 9 Jul 2020 

July 9 (Reuters) - Wolters Kluwer NV ::WOLTERS KLUWER LEGAL & REGULATORY U.S. ANNOUNCES PARTNERSHIP WITH OXFORD UNIVERSITY PRESS.PARTNERSHIP TO MAKE ITS ACCLAIMED TITLES AVAILABLE THROUGH KLUWER ARBITRATION, KLUWER COMPETITION LAW, AND KLUWER IP LAW..  Full Article

Wolters Kluwer Tax & Accounting Collaborates With Protiviti In Europe
Tuesday, 7 Jul 2020 

July 7 (Reuters) - Wolters Kluwer NV ::WOLTERS KLUWER TAX & ACCOUNTING EXPANDS PROFESSIONAL SERVICES FOR TEAMMATE EXPERT SOLUTIONS THROUGH A COLLABORATION WITH PROTIVITI LTD. IN EUROPE.  Full Article

Wolters Kluwer Prices EUR 500 Million 10-Year Eurobond
Friday, 26 Jun 2020 

June 26 (Reuters) - Wolters Kluwer NV ::WOLTERS KLUWER SUCCESSFULLY PRICES €500 MILLION 10-YEAR EUROBOND.SETTLEMENT DATE HAS BEEN SET AT JULY 3,2020.BONDS WERE SOLD AT AN ISSUE PRICE OF 99.292 PER CENT AND CARRY AN ANNUAL COUPON OF 0.750 PER CENT.NET PROCEEDS OF OFFERING WILL BE USED FOR GENERAL CORPORATE PURPOSES.NEW BOND PROVIDES FINANCING AT AN ATTRACTIVE RATE AND WILL EXTEND COMPANY'S DEBT MATURITY PROFILE.BANCA IMI, BANK OF AMERICA, CITI, AND DEUTSCHE BANK ACTED AS BOOKRUNNERS.BONDS WILL BE LISTED ON OFFICIAL LIST OF LUXEMBOURG STOCK EXCHANGE.  Full Article

Wolters Kluwer: Wolters Kluwer Tax & Accounting Partners With Br1ght
Wednesday, 17 Jun 2020 

June 17 (Reuters) - WOLTERS KLUWER NV ::WOLTERS KLUWER TAX & ACCOUNTING ANNOUNCES BR1GHT AS ITS IMPLEMENTATION PARTNER FOR TEAMMATE EXPERT SOLUTIONS IN THE NETHERLANDS AND THE NORDIC MARKETS.  Full Article

Wolters Kluwer: ING's China Business Chooses OneSumX
Monday, 1 Jun 2020 

June 1 (Reuters) - WOLTERS KLUWER NV ::UPDATES ONESUMX FOR REGULATORY REPORTING TO MEET SECOND-GENERATION PEOPLE’S BANK OF CHINA ENTERPRISE CREDIT REFERENCE SUBMISSION.ING'S CHINA BUSINESS HAS CHOSEN ONESUMX FOR REGULATORY REPORTING TO MANAGE SECOND-GENERATION PEOPLE'S BANK OF CHINA ENTERPRISE CREDIT REFERENCE SUBMISSION.WOLTERS KLUWER FRR, WHICH IS PART OF COMPANY'S GOVERNANCE, RISK & COMPLIANCE DIVISION, IS A GLOBAL MARKET LEADER IN PROVISION OF INTEGRATED REGULATORY COMPLIANCE AND REPORTING SOLUTIONS.  Full Article

Wolters Kluwer's CCH Tagetik Solution Chosen By InVivo
Tuesday, 26 May 2020 

May 26 (Reuters) - WOLTERS KLUWER NV ::INVIVO CHOOSES WOLTERS KLUWER'S CCH TAGETIK SOLUTION TO SUPPORT ITS GROWTH AND MODERNISE ITS FINANCIAL PROCESSES.  Full Article

Wolters Kluwer Partners With American Society Of Clinical Oncology
Thursday, 21 May 2020 

May 21 (Reuters) - WOLTERS KLUWER NV ::HAS ENTERED INTO A MULTI-YEAR AGREEMENT WITH THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO®).BEGINNING IN JANUARY 2021, WOLTERS KLUWER WILL PUBLISH ASCO’S PORTFOLIO OF FIVE MEDICAL SPECIALTY JOURNALS.  Full Article

Wolters Kluwer: West African Development Bank (BOAD) Chooses OneSumX
Thursday, 21 May 2020 

May 21 (Reuters) - WOLTERS KLUVER NV ::WEST AFRICAN DEVELOPMENT BANK (BOAD) CHOOSES WOLTERS KLUWER'S ONESUMX SOFTWARE FOR RISK MANAGEMENT.  Full Article

Wolters Kluwer Divests Stake In Logical Images For 11.6 Million Dollars
Friday, 15 May 2020 

May 15 (Reuters) - Wolters Kluwer NV ::WOLTERS KLUWER DIVESTS STAKE IN LOGICAL IMAGES.SIGNED AND COMPLETED AN AGREEMENT TO SELL ITS STAKE IN LOGICAL IMAGES, PROVIDER OF VISUAL DIAGNOSTIC RESOURCES, FOR $11.6 MILLION IN CASH.  Full Article

Wolters Kluwer To Provide Aegean Baltic Bank With Risk And Regulatory Reporting Software
Friday, 15 May 2020 

May 15 (Reuters) - WOLTERS KLUWER NV ::AEGEAN BALTIC BANK OF GREECE SELECTS WOLTERS KLUWER TO PROVIDE INTEGRATED RISK AND REGULATORY REPORTING SOLUTION.  Full Article

BRIEF-Wolters Kluwer Partners With American Society Of Clinical Oncology

* HAS ENTERED INTO A MULTI-YEAR AGREEMENT WITH THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO®)